Dr. Stephen A. Bart Sr., MD, CPI

Dr. Bart leads medical affairs for both the Clinical Site and CRO divisions of the organization. He is Board Certified in Family Medicine with a sub-specialty in Women’s Health and has been active as a clinical physician and researcher for more than 16 years. Prior to joining Accelovance, Dr. Bart held a senior executive position and was a member of the Board of Directors at Idis, Inc., a global organization with expertise in named patient programs (NPPs). He also served as Chief Medical Officer and Executive Director of Business Development and Client Services at SNBL Clinical Pharmacology Center, a Phase I inpatient unit and CRO in Baltimore, Maryland.

Dr. Bart is aligned with the innovative thinking of Accelovance and commitment to improving both predictability and quality of study conduct; enhancing the level of clinical solutions Accelovance can provide to clients. In addition to protocol development and international regulatory interactions, Dr. Bart has developed and managed teams for Quality Assurance, Medical Information, Medical Affairs, Regulatory Compliance and Study Management. Additional areas of therapeutic expertise include infectious disease, immunology, Women’s Health, metabolic disease, orphan drug development, oncology, rheumatoid disease.

Dr. Bart completed his undergraduate work at the University of Illinois and University of Northeastern Illinois, graduating with a Bachelor of Science in Biology and Chemistry. He received his Medical Degree from Rush University Medical College and further postgraduate training at the University of Pittsburgh and the University of South Florida. Dr. Bart has held faculty positions at Penn State University as well as the University of Maryland Medical Center. Dr. Bart has served as an industry KOL whose input is both sought after and valued by the international scientific community. He has served on various DSMB’s throughout his tenure, and continues to devote his efforts to the reduction of disease burden, and treatment to reduce patients suffering

Sheryl Littmann, MBA

 Sheryl is a Program Management Professional within the pharmaceutical industry specializing in clinical development, pharmacovigilance and regulatory operations.  With over 20 years of industry experience, Sheryl was an Associate Director at Pfizer and has held positions at Hoffmann La-Roche and Johnson and Johnson.  She has a plethora of global experiences in drug development, regulatory submissions and ICH/GCP/GxPV practices.  Sheryl is best known for her continuous improvement, cross-functional leadership and quality assurance enhancements.  She is currently working as an independent consultant.


Sheryl has also held roles in other parts of pharmaceutical and CRO businesses, including business development, sales operations, marketing and training.  This foundation has greatly contributed towards her understanding of how companies as a whole can gain an edge in the market.

She is trained in lean six sigma and project management methodology and holds a M.B.A. from Fordham University and a Biological Science from Rutgers University. 

Sheryl sits on the Board of Directors of the Healthcare Businesswomen's Association Metro Chapter.  She also volunteers her time to support children with learning disabilities


Dr. Stephen J. Hellebusch, Ph.D.

Steve is President of Hellebusch Research & Consulting, Inc., a research and consulting company that specializes in the design and analysis of projects for the pharmaceutical industry. Dr. Hellebusch founded Hellebusch, Inc. in 1992. The company offers marketing research, clinical marketing research, and consulting. Since 1992, Steve has handled a wide variety of projects, including large, logistically complex marketing research studies used in submissions to the Food and Drug Administration (FDA). He has also consulted on a number of marketing and marketing research issues

As a consultant, Steve founded the Marketing Research Department for Adams Respiratory Therapeutics, the makers of the brand Mucinex (now owned by Reckitt Benckiser). Steve's research was pivotal in the successful Nicorette and Nicoderm CQ switches. He was a member of the Bayer Primary Prevention team that presented to the FDA in December, 2003. He has published articles on label comprehension in several issues of Focus, the magazine of the Regulatory Affairs Professionals Society.

Steve began his research career at Burke Markting Research, Inc., where he worked on all types of consumer packaged goods. From Burke, he went to Mobil Chemical Company to work on the Hefty and Baggies brands. He left Mobil to go to Merrell Dow Pharmaceuticals, Inc. where he was in charge of all marketing research on nonprescription products, potential switch products, and several prescription products as well. He received his Ph.D. in Experimental Psychology from the University of Notre Dame, concentrating in research design, statistics, perception, and memory. In addition to his current project and consulting work, he has taught a tutorial for the American Marketing Association that emphasizes the importance of setting objectives correctly.


Sherine O. Aly

Sherry is the Founder, President, and CEO of BioCentric, Inc., a full-service, global, scientific and medical healthcare communications company.  BioCentric is committed to advance the science of medicine and promote optimal patient care by developing educational, training, and promotional programs for healthcare professionals, patients, caregivers, health administrators, and sales and medical representatives. Using a multichannel approach, BioCentric develops programs in a variety of media—digital, mobile, online, video, animation, print, and direct-mail—working with pharmaceutical companies (including 5 of the top 8 global companies), biotechnology companies, associations, and federal agencies.

Sherry has over 25 years of experience in healthcare education and marketing.  She began her career as a sales representative for Marion Laboratories (now part of Sanofi). Sherry then entered the medical communications field, where she worked for three medical communications firms in various roles in account and client services and, finally in senior management.  Sherry set out on her own in 2001 to start BioCentric, blending her love of science and design to build an organization that could make a positive impact on the health and wellbeing of patients and on the providers caring for them. 

Sherry is a graduate of the Philadelphia College of Pharmacy and Science (now known as the University of Sciences of Philadelphia) and holds a bachelor’s degree in pharmacy.  She also serves on the Advisory Board of the Child Abuse Research and Education (CARES) Institute, which serves 7 counties in southern New Jersey and provides training and education around the globe. 

Guy Pedilini

Guy is a proven, results oriented, hands on leader with significant experience in leading global and domestic organizational transformation and change. Throughout his career, he has consistently driven company strategy utilizing his leadership skills in change management, talent initiatives, communications, reengineering and employee engagement programs.

Guy has driven strategic change for publicly held and private organizations in both domestic and global settings in Technology, Sales, Marketing, Service, Manufacturing, Engineering, and Corporate staff functions. His broad industry experience has included Pharmaceutical, Healthcare, Financial and Insurance Services, Professional Services, Technology, Aerospace, Consumer Products, and Government Programs.

In his senior leadership roles, Guy has been a member of senior executive teams that have led the significant growth and transformation of global business. He has led Global Human Resource Organizations with responsibilities for employees in North and South America, EMEA and Asia. He has led due diligence and integration teams in numerous acquisitions in global firms. Guy is on the Board of Directors of and Chairman of the Compensation Committee of Elanex, a technology drive global language services provider.

Guy holds a Bachelor of Science from the University of Delaware and an MBA in Human Resource Management from Monmouth University. An adoptive father, Guy and Julie his wife are the founders of the Central Jersey Adoption Support Group and are activists for adoption. Guy has also been active in United Way, Big Brothers, and Special Olympics and is currently a founding member of the Board of Directors of NJ Jobs For America’s Graduates (JAG) as well as the Board of Directors of, a national non-profit 501 (c ) (3) financial assistance grant program.

INSIGHTS •   •   •   •   •   •   •   •   •   •   •  

Author: SuperUser Account Created: 9/6/2012 5:08 PM
NSGP Insights covers the disruptive forces in today's healthcare and life sciences industries - from technology to patient engagement to the people and organizations that are making a difference.
By Ken Kahtava on 7/1/2015 11:51 AM
There are myriad definitions of 'patient engagement' in today's healthcare environment. But how important is a single definition, and what does it mean to today's Health IT providers?